| Recruitment status | Suspended |
| Unique ID issued by UMIN | UMIN000024425 |
| Receipt No. | R000028109 |
| Scientific Title | Graduation Constraint Induced Movement therapy for Chronic Stroke patient with severe upper extremity paresis |
| Date of disclosure of the study information | 2017/03/31 |
| Last modified on | 2019/10/19 (Ver. 5) |
| Basic information | ||
| Public title | Graduation Constraint Induced Movement therapy for Chronic Stroke patient with severe upper extremity paresis | |
| Acronym | Graduation Constraint Induced Movement therapy for Chronic Stroke patient | |
| Scientific Title | Graduation Constraint Induced Movement therapy for Chronic Stroke patient with severe upper extremity paresis | |
| Scientific Title:Acronym | Graduation Constraint Induced Movement therapy for Chronic Stroke patient | |
| Region |
|
|
| Condition | ||
| Condition | Chronic Stroke | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To expand the indication of Constraint Induced Movement Therapy(CI-tx) for patients with more severe upper extremity paresis |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Fugl-Meyer upper motor score, SIAS motor score, WMFT pre- and post- intervention, 3M after the intervention |
| Key secondary outcomes | MAL14, Spasticity, Sensory function, Electrophysiologycal assessments(reciprocal inhibition) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | To interfere the movement of non-paretic limb | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | -Chronic Stroke patients with hemiplegia
-more than 6month from the onset -Mild cognitive dysfunction and/or aphasia is permitted with MMSE > 20/30 and to be able to understand the objective of this experiment and to cooperate with the intervention. -Independent in Ambulatory and basic ADL -SIAS proximal U/E >= 3, distal U/E >=1b -No contracture or severe pain |
|||
| Key exclusion criteria | contraindication for physical therapies | |||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Keio University School of Medicine | ||||||
| Division name | Department of Rehabilitation Medicine | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35 Shinano-machi Shinjuku-ku | ||||||
| TEL | 03-5363-3833 | ||||||
| meigenliukeio@mac.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Keio University School of Medicine | ||||||
| Division name | Department of Rehabilitation Medicine | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35 | ||||||
| TEL | +81905363-3833 | ||||||
| Homepage URL | |||||||
| s-tashiro@umin.net | |||||||
| Sponsor | |
| Institute | Keio University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | AMED |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Keio University School of Medicine |
| Address | Shinano-machi 35, Shinjuku city, Tokyo |
| Tel | 03-5363-3503 |
| med-rinri-jimu@adst.keio.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Suspended | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000028109 |